Infectivity of hepatic allografts with antibodies to hepatitis B virus

S. Forrest Dodson, Samir Issa, Victor Araya, Timothy Gayowski, Antonio Pinna, Bijan Eghtesad, Shunzaboro Iwatsuki, Eduardo Montalvo, Jorge Rakela, John J. Fung

Research output: Contribution to journalArticle

164 Scopus citations

Abstract

Background. Since suitable recipients for hepatic allografts from donors with antibodies to hepatitis B virus (HBV) have not been determined, a review of our 7-year experience with donors positive for hepatitis B surface antibody (anti-HBs), hepatitis B core antibody (anti-HBc), or both was undertaken. Methods. Recipients of hepatic allografts from donors with antibodies to HBV were identified by a retrospective review of procurement records and screened for HBV infection. Results. From January 1, 1990, to January 1, 1997, 2578 liver transplants were performed and 140 (5.4%) recipients received an allograft from a donor with antibodies to HBV. Twenty- five of 48 recipients of a hepatic allograft from a donor positive only for anti-HBs were screened and none developed HBV infection. Twenty-five of 41 naive recipients of a hepatic allograft from an anti-HBc positive donor were screened and 18/25 (72%) developed HBV infection. Four of these 18 naive recipients with HBV infection received an allograft from a donor positive for beth anti-HBc and anti-HBs. Seven of 13 anti-HBs-positive recipients of an allograft from an anti-HBc-positive donor were screened and none developed HBV infection. Fifteen of 16 recipients positive only for anti-HBc who received a hepatic allograft from an anti-HBc-positive donor were screened and 2/15 (13%) developed HBV infection. Conclusions. Hepatic allografts from donors positive only for anti-HBs do not transmit HBV infection. Hepatic allografts from anti-HBc-positive donors frequently transmit HBV infection to naive recipients regardless of the donor anti-HBs status, and antiviral prophylaxis may be indicated. Anti-HBs-positive recipients appear resistant to HBV infection after orthotopic liver transplantation with an allograft from an anti-HBc-positive donor. Recipients positive only for anti-HBc infrequently develop HBV infection when transplanted with an allograft from an anti-HBc-positive donor; however, HBV prophylaxis may be justified.

Original languageEnglish (US)
Pages (from-to)1582-1584
Number of pages3
JournalTransplantation
Volume64
Issue number11
DOIs
StatePublished - Dec 15 1997

ASJC Scopus subject areas

  • Transplantation

Fingerprint Dive into the research topics of 'Infectivity of hepatic allografts with antibodies to hepatitis B virus'. Together they form a unique fingerprint.

  • Cite this

    Dodson, S. F., Issa, S., Araya, V., Gayowski, T., Pinna, A., Eghtesad, B., Iwatsuki, S., Montalvo, E., Rakela, J., & Fung, J. J. (1997). Infectivity of hepatic allografts with antibodies to hepatitis B virus. Transplantation, 64(11), 1582-1584. https://doi.org/10.1097/00007890-199712150-00013